Astrocytes phenomics as new druggable targets in healthy aging and Alzheimer’s disease progression
For over a century after their discovery astrocytes were regarded merely as cells located among other brain cells to hold and give support to neurons. Astrocytes activation, “astrocytosis” or A1 functional state, was considered a detrimental mechanism against neuronal survival. Recently, the scienti...
Saved in:
Main Authors: | Daniele Lana, Filippo Ugolini, Ludovica Iovino, Selene Attorre, Maria Grazia Giovannini |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Cellular Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fncel.2024.1512985/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SIRT2 and ALDH1A1 as critical enzymes for astrocytic GABA production in Alzheimer’s disease
by: Mridula Bhalla, et al.
Published: (2025-01-01) -
Quantification and correlation of amyloid-β plaque load, glial activation, GABAergic interneuron numbers, and cognitive decline in the young TgF344-AD rat model of Alzheimer’s disease
by: Anett Futácsi, et al.
Published: (2025-02-01) -
Cognitive disorders: Potential astrocyte-based mechanism
by: Shiyu Li, et al.
Published: (2025-01-01) -
Lipidopathy disrupts peripheral and central amyloid clearance in Alzheimer's disease: Where are our knowledge
by: Shahram Darabi, et al.
Published: (2025-06-01) -
Deciphering the Role of Adrenergic Receptors in Alzheimer’s Disease: Paving the Way for Innovative Therapies
by: Androulla N. Miliotou, et al.
Published: (2025-01-01)